Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Plos One|August 20, 2019
The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumoniaRyo Yamazaki, Osamu Nishiyama, Sho Saeki, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 17, 2003
Asthma health status: influence of disease severity categorized by peak expiratory flowOsamu Nishiyama, Keisuke Kato, Hiroaki Kume, et al.
Plos One|April 25, 2020
Characteristics of patients with chronic idiopathic interstitial pneumonia undergoing repeated respiratory-related hospitalizations: A retrospective cohort studyRyo Yamazaki, Osamu Nishiyama, Sho Saeki, et al.
Internal Medicine (Tokyo, Japan)|April 4, 2014
Acute coronary syndrome caused by coronary vasospasms associated with Churg-Strauss syndrome: effects of betamethasone therapyYuji Suzuki, Osamu Nishiyama, Toshiaki Sakai, et al.
Clinical and Experimental Pharmacology & Physiology|March 11, 2004
Role of lysophosphatidylcholine in eosinophil infiltration and resistance in airwaysOsamu Nishiyama, Hiroaki Kume, Masashi Kondo, et al.
Scientific Reports|March 12, 2021
Initial therapeutic dose of corticosteroid for an acute exacerbation of IPF is associated with subsequent early recurrence of another exacerbationRyo Yamazaki, Osamu Nishiyama, Sho Saeki, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2014
Mediastinal fibrosis and positive antineutrophil cytoplasmic antibodies: coincidence or common etiology?Hiroshi Santo, Osamu Nishiyama, Hiroyuki Sano, et al.
Canadian Respiratory Journal|July 23, 2016
Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung DiseaseOsamu Nishiyama, Ryo Yamazaki, Hiroyuki Sano, et al.
Respiratory Investigation|January 13, 2018
Physical activity in daily life in patients with idiopathic pulmonary fibrosisOsamu Nishiyama, Ryo Yamazaki, Hiroyuki Sano, et al.
Biochemistry and Biophysics Reports|September 6, 2021
The phosphodiesterase 4 inhibitor AA6216 suppresses activity of fibrosis-specific macrophagesTakashi Matsuhira, Osamu Nishiyama, Yuji Tabata, et al.
Pageof 12